Viral vector-mediated transduction of a modified platelet factor 4 cDNA inhibits angiogenesis and tumor growth

Nature Medicine

Volumn 3, Issue 4, 1997, Pages 437-442

  Tanaka, Toshihide ^a   Manome, Yoshinobu ^a   Wen, Patrick ^b   Kufe, Donald W ^a   Fine, Howard A ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

THROMBOCYTE FACTOR 4; VIRUS VECTOR;

ANGIOGENESIS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; GENE TRANSFER; GROWTH INHIBITION; MITOSIS INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT;

ADENOVIRIDAE; ANIMALS; BRAIN NEOPLASMS; GENE THERAPY; GENETIC VECTORS; GLIOBLASTOMA; GLIOMA; HUMANS; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; PLATELET FACTOR 4; RATS; RETROVIRIDAE; SURVIVAL ANALYSIS; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

ANIMALIA;

EID: 0030937456     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0497-437     Document Type: Article

References (30)

1. Folkman, J. Tumor angiogenesis: Therapeutic implications. New Engl. J. Med. 285, 1182-1186 (1971).
2. Brem S., Cotran, R. & Folkman, J. Tumor angiogenesis: A quantitative method for histologic grading. J. Natl. Cancer Inst. 48, 347-356 (1972).
3. Brem, S. The role of vascular proliferation in the growth of brain tumors. Clin. Neurosurg. 23, 440-453 (1976).
4. Maxwell, M. et al. Expression of angiogenic growth factor genes in primary human astrocytomas may contribute to their growth and progression. Cancer Res. 51, 1345-1351 (1991).
5. Shweiki, D., Itin, A., Soffer, D. & Keshet, E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359, 843-845 (1992).
6. Plate, K.H., Breier, G., Weich, H.A. & Risau, W. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 359, 845-848 (1992).
7. O'Reilly, M.S. et al. Angiostatin: A novel angiostatin inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79, 315-328 (1994).
8. Ingber, D. et al. Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumor growth. Nature 348, 555-557 (1990).
9. D'Amato, R.J., Loughnan, M.S., Flynn, E. & Folkman, J. Thalidomide is an inhibitor of angiogenesis. Proc. Natl. Acad. Sci. USA 91, 4082-4085 (1994).
10. Maione, T.E. et al. Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides. Science 247, 77-79 (1990).
11. Maione, T.E., Cray, G.S., Hunt, A.J. & Sharpe, R.J. Inhibition of tumor growth in mice by an analogue of platelet factor 4 that lacks affinity for heparin and retains potent angiostatic activity. Cancer Res. 51, 2077-2083 (1991).
12. Sharpe, R.J., Eyers, H.R., Scott, C.F., Bauer, S.I. & Maione, T.E. Growth inhibition of murine melanoma and human colon carcinoma by recombinant human platelet factor 4. J. Natl. Cancer Inst. 82, 848-853 (1990).
13. Staddon, A. St Bonnem, E. A randomized dose finding study of recombinant platelet factor 4 (rPF4) in cutaneous AIDS-related Kaposi's sarcoma (KS). Proc. Am. Soc. Clin. Oncol. 13, 3 (1994).
14. O'Reilly, M.S., Holmgren, L., Chen, C. & Folkman, J. Angiostatin induces and sustains dormancy of human primary tumors in mice. Nature Med. 2, 689-692 (1996).
15. Millauer, B., Shawver, L.K., Plate, K.H., Risau, W. & Ullrich, A. Clioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant. Nature 367, 576-579 (1994).
16. Weinstat-Saslow, D.L., Zabrenetzky, V.S., Frazier, W.A., Roberts, D.D. & Steeg, P.S. Transfection of thrombospondin 1 complementary DNA into a human breast carcinoma cell line reduces primary tumor growth, metastatic potential and angiogenesis. Cancer Res. 54, 6504-6511 (1994).
17. Millauer, B. et al. Dominant-negative inhibition of Flk-1 suppresses the growth of many tumor types in vivo. Cancer Res. 56, 1615-1620 (1996).
18. Rice, C.D. & Merchant, R.E. Systemic treatment with murine recombinant interleukin-1β inhibits the growth and progression of malignant glioma in the rat. J. Neuro-Oncol. 13, 43-55 (1992).
19. Takamiya, Y., Brem, H., Ojeifo, J., Mineta, T. & Martuza, R.L. AGM-1470 inhibits the growth of human glioblastoma cells in vitro and in vivo. Neurosurgery 34, 869-875 (1994).
20. Holmgren, L., O'Reilly, M.S. & Folkman, J. Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nature Med. 1, 149-153 (1995).
21. Alon, T. et al. Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nature Med. 1, 1024-1028 (1995).
22. Hamada, J., Cavanaugh, P.C., Lotan, O. & Nicolson, G.L. Separable growth and migration factors for large cell lymphoma cells secreted by microvascular endothelial cells derived from target organs for metastasis. Br. J. Cancer 66, 349-354 (1992).
23. Graeber, G.G. et al. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumors. Nature 379, 88-91 (1996).
24. Fine, H.A. Prospects for gene therapy as an innovative approach to malignant gliomas. Perspect. Neurol. Surg. 5, 115-127 (1994).
25. Chen, S.-H., Shine, H.D., Goodman, J.C., Grossman, R.G. & Woo, S.L.C. Gene therapy for brain tumor: Regression of experimental gliomas by adenovirus-mediated gene transfer in vivo. Proc. Natl. Acad. Sci. USA 91, 3054-3057 (1994).
26. Dong, Y. et al. In vivo replication-deficient adenovirus vector-mediated transduction of the cytosine deaminase gene sensitizes glioma cells to 5-fluorocytosine. Hum. Gene Ther. 7, 713-720 (1996).
27. Hochberg, F.H. & Pruitt, A. Assumptions in the radiotherapy of glioblastomas. Neurology 30, 907-991 (1980).
28. McGrory, W.J., Bautista, D.S. & Graham, F.L. A simple technique for the rescue of early region 1 mutations into infectious human adenovirus type 5. Virology 163, 614-617 (1988).
29. Graham, F.L., Smiley, J., Russel, W.C. & Nairn, R. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 36, 59-72 (1977).
30. Takamiya, Y., Friedlander, R.M., Brem, H., Malick, A. & Martuza, R.L. Inhibition of angiogenesis and growth of human nerve-sheath tumors by AGM-1470. J. Neurosurg. 78, 470-476 (1993).